Stock listing
NASDAQ:NBRV Nabriva Therapeutics AG Stock
Follow Nabriva Therapeutics AG into a list and get an email when it puts out news.
Delisted NASDAQ:NBRV no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:NBRV
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Nabriva Therapeutics AG on 6ix
- Calls
- 7 calls with a replay · 7 with a transcript · latest Nov 10, 2022
- Decks
- 11 decks · latest Apr 15, 2021
Events
| Call | When | Status |
|---|---|---|
| Nabriva Therapeutics (NBRV) Q3 2022 Earnings Call | Thu, Nov 10, 2022 · 3:30 AM ET | Replay |
| Nabriva Therapeutics (NBRV) Q2 2022 Earnings Call | Wed, Aug 03, 2022 · 4:30 PM ET | Replay |
| Nabriva Therapeutics (NBRV) Q4 2021 Earnings Call | Tue, Mar 29, 2022 · 4:30 PM ET | Replay |
| Nabriva Therapeutics (NBRV) Q3 2021 Earnings Call | Tue, Nov 09, 2021 · 4:30 PM ET | Replay |
| Nabriva Therapeutics (NBRV) Q2 2021 Earnings Call | Thu, Aug 05, 2021 · 4:30 PM ET | Replay |
| Nabriva Therapeutics (NBRV) Q1 2021 Earnings Call | Mon, Apr 05, 2021 · 4:30 PM ET | Replay |
| Nabriva Therapeutics (NBRV) Q4 2020 Earnings Call | Thu, Mar 11, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (April 2021) | Investor deck | 30 slides | Apr 15, 2021 |
| Q3 2019 Earnings Presentation | Earnings | 27 slides | Nov 12, 2019 |
| Technical Presentation (May 2018) | Technical | 36 slides | May 21, 2018 |
| Investor Presentation (November 2017) | Investor deck | 57 slides | Nov 7, 2017 |
| Conference Presentation (September 2017) | Conference | 28 slides | Sep 18, 2017 |
| Investor Day (June 2017) | Investor day | 49 slides | Jun 19, 2017 |
| Investor Presentation (April 2017) | Investor deck | 35 slides | Apr 5, 2017 |
| Investor Presentation (February 2017) | Investor deck | 34 slides | Feb 15, 2017 |
| Investor Presentation (January 2017) | Investor deck | 29 slides | Jan 9, 2017 |
| Investor Presentation (April 2016) | Investor deck | 31 slides | Apr 12, 2016 |
All 11 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2015) | Investor deck | 17 slides | Nov 10, 2015 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Stephen Webster Other companies: Cullinan Therapeutics, Inc. (Chair of the Audit Committee · Since at least Jan 7, 2021); NextCure, Inc. (Director · Since at least May 8, 2019); Gritstone bio, Inc. (Director · Apr 26, 2024 – Apr 4, 2025 · Past); Tcr2 Therapeutics Inc (Director · Apr 30, 2020 – Jun 1, 2023 · Past); Viking Therapeutics, Inc. (Director · Apr 28, 2015 – Jan 2, 2020 · Past); Spark Therapeutics Inc (CHIEF FINANCIAL OFFICER · Jan 29, 2015 – Dec 17, 2019 · Past); Optimer Pharmaceuticals Inc (Chief Financial Officer · Jun 25, 2012 – Oct 24, 2013 · Past); Adolor Corp (SVP, Finance & CFO · Sep 9, 2010 – Dec 12, 2011 · Past) | Director · Dec 30, 2016 – Aug 2, 2022 · Past |
| John Peter Wolf III Other companies: Aceragen Inc. (General Counsel · Dec 10, 2014 – Dec 10, 2014 · Past); Viropharma Inc (VP, General Counsel · Jun 10, 2013 – Jan 24, 2014 · Past) | General Counsel and Corp. Sec. · Dec 30, 2016 – Dec 30, 2016 · Past |
| Colin MD Broom | Director · Aug 2, 2022 – Aug 2, 2022 · Past |
| Elyse G Seltzer | Chief Medical Officer · Dec 30, 2016 – Jun 23, 2017 · Past |
| Francesco Maria Lavino | Chief Commercial Officer · Jul 10, 2017 – Sep 30, 2020 · Past |
| Jennifer Schranz | Chief Medical Officer · Sep 30, 2020 – Feb 28, 2021 · Past |
| Lisa Dalton | Director · Jun 2, 2021 – Jul 31, 2022 · Past |
Log in to ask 6ix AI your own questions about Nabriva Therapeutics AG.